Search
Seventure
Calls for genuine corporate responsibility efforts have been high on the agenda for some time, but the pandemic — and its wide-ranging impact on all organisations, including...
MaaT Pharma announced today positive topline results from its Phase 2 clinical trial evaluating lead microbiome ecosystem therapy, MaaT013, in a high-risk patient population...
YSOPIA Bioscience, a French clinical stage biotechnology company specializing in the research and development of innovative drugs using the properties of key bacterial strains...
BiomX Inc. (NYSE American: PHGE), a clinical-stage company developing both natural and engineered phage therapies that target specific pathogenic bacteria, today announced that...
Izicap, the european card-linked CRM & loyalty platform leader, has been awarded "Best POS/Payment Solution" by the merchant payments ecosystem organisation within their...
Seventure led $10M round for new French company focusing on I/O-microbiome and provided $3M seed funding to ErVaccine, driving an increased I/O microbiome focus in fund...
Proteon Pharmaceuticals announced a strategic partnership with Skretting aimed at providing functional solutions to tackle health challenges in the aquaculture industry. The...
In recent years, the understanding of how the microbiome and human health are linked has expanded considerably. We believe the rise in this understanding and the growing...
While the pandemic might have caused some disruption, microbiome research hasn’t slowed down at all, notes Isabelle de Cremoux, CEO and Managing Partner, Seventure...
European life sciences investment firm Seventure Partners has extended the final close of its second microbiome innovation fund and increased focus on advances in the skin...
